Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

a50c02ec-6ba9-4678-990d-6c74a8e9b7b5

497e0e81-d73f-5ece-978c-91e5a2a013c6

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
age_years
53

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • BILE_ACID_METABOLISM+0.110
  • KRAS_SIGNALING_DN+0.100
  • WNT_BETA_CATENIN_SIGNALING+0.100
  • PEROXISOME+0.070
  • MYC_TARGETS_V2+0.060
  • MITOTIC_SPINDLE+0.050
  • SPERMATOGENESIS+0.030
  • G2M_CHECKPOINT-0.060
  • ESTROGEN_RESPONSE_EARLY-0.110
  • HEME_METABOLISM-0.120

Top 10 suppressed

  • ALLOGRAFT_REJECTION-0.570
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.560
  • INTERFERON_GAMMA_RESPONSE-0.510
  • ANGIOGENESIS-0.500
  • TNFA_SIGNALING_VIA_NFKB-0.500
  • IL6_JAK_STAT3_SIGNALING-0.440
  • INFLAMMATORY_RESPONSE-0.440
  • INTERFERON_ALPHA_RESPONSE-0.430
  • KRAS_SIGNALING_UP-0.420
  • COMPLEMENT-0.410

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

1 twin match this tumor's tissue · 9 come from a different tissue of origin ← cross-tissue dominant

#SampleCancer typeSubtypecos similarity
1SRR1478096
brain-umap@2
GTEX0.935
2SRR1456514
brain-umap@2
GTEX0.935
3SRR1377984
brain-umap@2
GTEX0.935
4SRR1324452
brain-umap@2
GTEX0.934
5SRR607967
brain-umap@2
GTEX0.933
6SRR1467255
brain-umap@2
GTEX0.930
7TCGA-L9-A7SV-01A-11R-A39D-07
lung-landscapes@6
cohortA10.930
8SRR1322291
brain-umap@2
GTEX0.929
9SRR1398992
brain-umap@2
GTEX0.929
10SRR1341605
brain-umap@2
GTEX0.926

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 7 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
BILE_ACID_METABOLISM0.110Inavolisib— uncovered
KRAS_SIGNALING_DN0.100Remibrutinib— uncovered
WNT_BETA_CATENIN_SIGNALING0.100Inavolisib— uncovered
PEROXISOME0.070Idelalisib— uncovered
MYC_TARGETS_V20.060Idelalisib— uncovered
MITOTIC_SPINDLE0.050Inavolisib— uncovered
SPERMATOGENESIS0.030Inavolisib— uncovered